Antiparasitic Collar

Verify with FDA CVM →

23 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
23
Total Reports
1
Deaths Reported
430.0%
Death Rate

Active Ingredients

Antiparasitic Collar

Administration Routes

TopicalUnknownCutaneous

Species Affected

Dog 14
Cat 9

Most Affected Breeds

Domestic Shorthair 8
Retriever - Labrador 4
Crossbred Canine/dog 2
Dog (other) 1
Lhasa Apso 1
Beagle 1
Pit Bull 1
Terrier - Yorkshire 1
Bullmastiff 1
Domestic Longhair 1

Most Reported Reactions

Vocalisation 6
Scratching 4
Behavioural disorder NOS 4
Skin scab 4
Increased heart rate 4
Neutrophilia 4
Lethargy (see also Central nervous system depression in 'Neurological') 3
Vomiting 3
Hyperactivity 3
Other abnormal test result NOS 3
Hyperexcitation 3
Anorexia 3

Outcome Breakdown

Recovered/Normal
10 (43.5%)
Outcome Unknown
8 (34.8%)
Ongoing
4 (17.4%)
Euthanized
1 (4.3%)

Data Summary

Metric Value
Total adverse event reports 23
Reports involving death 1
Case-fatality rate (reported events) 430.0%
Distinct species in reports 2
Distinct breeds in reports 12
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Antiparasitic Collar Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 23 adverse event reports referencing Antiparasitic Collar, including 1 reports in which the animal died — a 430.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Antiparasitic Collar. Reported administration routes include Topical, Unknown, Cutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Antiparasitic Collar reports are Dog (14 reports), Cat (9 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (8), Retriever - Labrador (4), Crossbred Canine/dog (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Antiparasitic Collar are Vocalisation (6), Scratching (4), Behavioural disorder NOS (4), Skin scab (4). Of the 23 reports with a coded outcome, Recovered/Normal is the leading category at 43.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Antiparasitic Collar.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial